Combining Daratumumab with VRd Improves Outcomes in Patients with Transplant-Ineligible or Transplant-Deferred Newly Diagnosed Multiple Myeloma By Ogkologos - March 3, 2025 571 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the CEPHEUS study Source RELATED ARTICLESMORE FROM AUTHOR Noninferiority of OS with 3 Months Compared to 6 Months of Adjuvant Chemotherapy for Patients with High-Risk Stage III Colorectal Cancer Patient Guide on Bone Health in Cancer Now Available Also in French Lung Cancer Death Rates Among Women in Europe Are Finally Levelling Off MOST POPULAR Immunotherapy approved for some people with advanced melanoma in England December 21, 2021 Nirogacestat Shows Significant Benefit in Patients with Progressing Desmoid Tumours March 20, 2023 Targeted Therapy Based on Molecular Profiling of Malignant Mesothelioma Tumours Is... October 19, 2020 FDA Grants Regular Approval to Venetoclax in Combination for Untreated Acute... October 26, 2020 Load more HOT NEWS “Supporting research is mission critical for me and always will be”... The UK Government’s spending review: Time to invest in the future... Addressing Disparities and Raising Awareness During National Black Family Cancer Awareness... 21-Month-Old Girl Celebrates After Beating Stage 4 Cancer
